---
title: "300436.SZ (300436.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300436.SZ/news.md"
symbol: "300436.SZ"
name: "300436.SZ"
parent: "https://longbridge.com/en/quote/300436.SZ.md"
datetime: "2026-05-19T21:44:22.575Z"
locales:
  - [en](https://longbridge.com/en/quote/300436.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300436.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300436.SZ/news.md)
---

# 300436.SZ (300436.SZ) — Related News

### [Cosunter established a new company in Hainan with a registered capital of 10 million](https://longbridge.com/en/news/285333539.md)
*2026-05-06T07:59:17.000Z*
> According to the Tianyancha App, recently, Cosunter Pharmaceutical Co., Ltd. was established, with Li Zhenyang as the le

### [Cosunter: Net loss of 25.9243 million yuan in the first quarter of 2026](https://longbridge.com/en/news/284381327.md)
*2026-04-28T12:08:00.000Z*
> Cosunter announced that in the first quarter of 2026, the operating revenue was 98.4402 million yuan, a year-on-year inc

### [](https://longbridge.com/en/news/283423182.md)
*2026-04-21T01:40:16.000Z*
> The A-share pharmaceutical sector was active at the beginning of the trading session, with YIBAI PHARMACEUTICAL hitting 

### [The 4x bull stock Cosunter's private placement plan underwent significant adjustments after two rounds of inquiries: the fundraising amount was reduced by over 250 million yuan, and the traditional Chinese medicine project was removed](https://longbridge.com/en/news/283104477.md)
*2026-04-17T07:13:14.000Z*
> Cosunter recently adjusted its private placement plan, reducing the total fundraising amount from 977 million yuan to 72

### [Innovative drug concept stocks have pulled back, with Salubris and other stocks falling over 6%](https://longbridge.com/en/news/282921654.md)
*2026-04-16T01:51:44.000Z*
> Innovative drug concept stocks have pulled back, with Salubris and Cosunter down over 6%, and Staidson BioPharm and Suns

### [](https://longbridge.com/en/news/281815620.md)
*2026-04-07T01:41:35.000Z*
> Innovative drug concept stocks rapidly plummeted, with NEPTUNUS hitting the daily limit, RemeGen falling more than 10%, 

### [](https://longbridge.com/en/news/281816091.md)
*2026-04-07T01:38:37.000Z*
> The A-share innovative drug sector has pulled back and weakened, with NEPTUNUS falling over 9%, Cosunter dropping over 6

### [Institution-led, nearly a 30% surge in three days! Cosunter states that the innovative hepatitis B drug is still in the research stage](https://longbridge.com/en/news/281764514.md)
*2026-04-06T13:18:20.000Z*
> On the evening of April 6th, Cosunter (300436) announced that the closing price increase deviation of the company's stoc

### [Cosunter: The company's innovative hepatitis B drug is still in the research stage](https://longbridge.com/en/news/281743641.md)
*2026-04-06T08:52:03.000Z*
> Cosunter announced that its innovative hepatitis B drug is still in the research and development stage. Due to the long